Home/Filings/4/A/0001437749-23-009766
4/A//SEC Filing

McClung David 4/A

Accession 0001437749-23-009766

CIK 0000925741other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:45 PM ET

Size

5.3 KB

Accession

0001437749-23-009766

Insider Transaction Report

Form 4/AAmended
Period: 2022-05-12
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-05-12$1.32/sh17,347$22,89879,803 total
Footnotes (3)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person.
  • [F2]The original Form 4 incorrectly reported that 20,632 shares had been withheld due to a clerical error. The corrected number is reported herein.
  • [F3]The original Form 4 incorrectly reported that 76,518 shares were beneficially owned following the reported transaction. The corrected amount is reported herein.

Documents

1 file

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001686155

Filing Metadata

Form type
4/A
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:45 PM ET
Size
5.3 KB